Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
3
×
life sciences
national blog main
3
×
national top stories
new york top stories
novartis
3
×
amgen
boston blog main
boston top stories
national
new york blog main
san francisco top stories
alder biopharmaceuticals
alirocumab
alnylam pharmaceuticals
billy dunn
biogen
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
david rind
deals
detroit blog main
detroit top stories
drug prices
drug pricing
eli lilly
episodic migraine
eptinezumab
erenumab
europe top stories
evolocumab
evrysdi
food and drug administration
fremanezumab
galcanezumab
gene therapy
What
drug
3
×
fda
new
medicines
acquire
agreed
amgen
approval
approved
atrophy
billion
brings
candidates
cash
cholesterol
class
company
compound
daily
deal
developed
evrysdi
friday
gets
green
head
home
intended
lights
liquid
medco
medicine
migraine
muscular
nod
novartis
oral
pain
patients
poised
Language
unset
Current search:
novartis
×
fda
×
" national blog main "
×
drug
×
@xconomy.com
4 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines